Top 10 Fastest Growing Medical Device Companies in 2025, According to the Financial Times

The medical device and medtech industries continue to transform patient care, driven by advances in wearable monitoring, robotic-assisted interventions and integrated data platforms. Alongside these innovations, rising healthcare labor shortages have accelerated demand for user-friendly, remote-capable technologies that reduce burden on clinical staff.

According to Fortune Business Insights, the US medical devices market alone is projected to exceed $250 billion by 2025. This is fueled by rising aging populations, chronic disease prevalence and a growing emphasis on home-based healthcare.

In 2025, The Financial Times (FT) recognized a new wave of medtech companies leading in absolute growth rates and revenue acceleration. From implantable glucose monitors to digital cardiac monitoring platforms, the following 10 companies stood out not only for their financial performance but also for advancing how health conditions are monitored, treated and managed today.

Here’s a closer look at the top 10 fastest growing medical device companies in this year’s FT ranking — and the milestones that helped them get there.

Procept BioRobotics (Absolute Growth: 1,664.8%)

California-based Procept BioRobotics develops robot-assisted surgical platforms for benign prostatic hyperplasia (BPH). At the 2025 American Urological Association Meeting, new data showed that their aquablation therapy — a waterjet-based, robotically delivered treatment — provided durable symptom relief and preserved sexual function over five years. The company also expanded its technology portfolio with the commercial launch of the HYDROS robotic system and continued advancing new indications for aquablation therapy.

CVRx (Absolute Growth: 549.2%)

Minnesota-based CVRx designs implantable neuromodulation devices to address heart failure and hypertension. New real-world evidence presented at the Technology and Heart Failure Therapeutics (THT) 2025 conference showed Barostim therapy — which uses electrical impulses to improve cardiovascular function — led to an 86% reduction in all-cause hospital visits and a significant drop in hospital stays. The findings, published in the Journal of Cardiac Failure, add strong real-world validation to Barostim’s clinical impact.

RxSight (Absolute Growth: 507.0%)

RxSight, headquartered in California, specializes in adjustable intraocular lenses that allow cataract patients to refine their vision after surgery. Its Light Adjustable Lens technology uses UV light to customize vision after implantation, offering flexibility that standard lenses cannot. In 2024, the company grew its revenue by 57%, fueled by a 79% rise in Light Adjustable Lens sales and a 46% expansion in its Light Delivery Device installed base.

Inspire Medical Systems (Absolute Growth: 442.0%)

From Minnesota, Inspire Medical Systems develops implantable devices to treat obstructive sleep apnea by stimulating airway muscles during sleep, offering an alternative to CPAP machines. In 2024, the company expanded its footprint to 1,435 centers offering Inspire therapy, with over 90,000 patients treated. Inspire is also preparing to launch its next-gen Inspire V system, adding to its sleep apnea solutions.

electroCore (Absolute Growth: 359.0%)

Based in New Jersey, electroCore focuses on non-invasive vagus nerve stimulation (nVNS) therapies for migraine and headache management. Last year, its Truvaga Plus handheld device won a 50 Over 50 Award for its role in promoting stress relief and better sleep. The company also announced plans to acquire NeuroMetrix and its Quell neuromodulation platform. The acquisition will expand its presence in non-invasive treatments for fibromyalgia and chronic pain.

Senseonics (Absolute Growth: 352.0%)

With headquarters in Maryland, Senseonics is known for its long-term implantable continuous glucose monitoring (CGM) systems. The company launched Eversense 365, the world’s first continuous glucose monitor (CGM) designed to last a full year with a single sensor. It also partnered with SweetSpot to enhance virtual patient monitoring. Senseonics grew its global patient base by 56% and is expanding its reach with regulatory submissions in Europe.

Biotricity (Absolute Growth: 256.4%)

California-based Biotricity develops connected cardiac monitoring devices for patients managing chronic heart conditions. The company partnered with B-Secur to launch a device-neutral ambulatory cardiac monitoring platform. The platform helps providers use different heart monitoring devices while obtaining faster, more accurate readings. Biotricity is also drawing plans to deliver comprehensive cardiac care through integrated monitoring technologies.

Axonics (Absolute Growth: 228.5%)

Headquartered in California, Axonics manufactures neuromodulation systems for treating bladder and bowel dysfunction. Its growth and innovation in overactive bladder therapies led to a $3.7 billion acquisition by Boston Scientific in late 2024. Axonics’ technologies are now strengthening Boston Scientific’s portfolio in the fast-growing urology and neuromodulation markets.

Haytek Lentes (Absolute Growth: 98.7%)

Operating from Brazil, Haytek Lentes manufactures advanced ophthalmic lenses and other vision correction technologies. Their portfolio includes progressive, single-vision and blue-light protection lenses, supported by high-performance coatings for clarity and durability. Haytek Lentes continues to expand its manufacturing capabilities for optical health solutions in Latin America and beyond.

HCT Solutions (Absolute Growth: 88.0%)

With roots in diagnostic imaging, US-based HCT Solutions specializes in providing critical systems, equipment and services for life sciences and biopharma manufacturing. Their expertise in controlled environments and process infrastructure supports the production of therapies, vaccines and other vital healthcare innovations. HCT Solutions was named among the fastest growing companies in New England, as ranked by The Boston Globe.

If you want your company to be featured on Xtalks.com, please email [email protected].